RCM
ENZY

Rotella Capital Management’s Enzymotec Ltd ENZY Stock Holding History

Rotella Capital Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17,118
Closed -$155K – 652
2015
Q3 		$155K Buy
+17,118
New +$153K 0.05% 359

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rotella Capital Management's ENZY Position: Q4 2015 in Review

Rotella Capital Management sold out of Enzymotec Ltd (ENZY) in Q4 2015, closing a stake of 17,118 shares — an estimated $155K sold.

Rotella Capital Management first reported a position in ENZY in Q3 2015 and held it in 1 quarter. The position peaked at $155K in Q3 2015. 30 funds tracked by Wall St. Rank hold ENZY as of Q4 2015.

  • Rotella Capital Management reported no remaining Enzymotec Ltd position as of Q4 2015 after selling out during the quarter.
  • Rotella Capital Management sold 17,118 Enzymotec Ltd shares in Q4 2015, an estimated $155K.
  • Rotella Capital Management first reported a position in Enzymotec Ltd in Q3 2015 and held it in 1 quarter.
  • Rotella Capital Management's Enzymotec Ltd position peaked at $155K in Q3 2015.
  • 30 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.